Accelerating Clinical Trial Activation Across Latin America

Launching clinical trials across multiple countries requires navigating varying regulatory requirements, site contracts, translations, import/export processes, and site engagement activities, all while maintaining alignment across sponsors, sites, and regional partners. Without effective coordination and visibility, disconnected workstreams can create delays, increase execution risk, and impact recruitment timelines. Insights from this case study demonstrate how a centralized oversight model helped two emerging biotech companies accelerate clinical trial activation across Latin America.

By combining regional expertise with a stage-gated governance framework, ProPharma established country-specific readiness criteria, standardized activation processes, and aligned stakeholders around a shared critical path. Enhanced dependency management and transparent reporting provided end-to-end visibility across feasibility, regulatory, contracting, start-up, and site activation activities, enabling proactive issue resolution and more informed decision-making.

The result was a scalable activation model that accelerated site readiness and activation timelines across participating countries while maintaining alignment between activation and enrollment objectives. Through coordinated execution, proactive issue management, and sustained operational oversight, the program exceeded regional enrollment expectations and created a repeatable framework for future studies